Crinetics raises $40M series A

Crinetics Pharmaceuticals Inc. (San Diego, Calif.) raised $40 million in a series A round led by 5AM Ventures, Versant Ventures and Vivo Capital. The company is developing an oral, once-daily somatostatin agonist to treat acromegaly. The program is in preclinical development. ...